Efficacy of dulaglutide 1.5 mg combined with insulin in older, poorly controlled insulin-treated patients with long-standing type 2 diabetes: a post-hoc analysis

被引：0
|
作者：
Lando, L. Fernandez [1 ]
Patel, H. [1 ]
Yu, M. [2 ]
Pantalone, K. M. [3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
[2] Eli Lilly & Co, Toronto, ON, Canada
[3] Cleveland Clin, Dept Endocrinol, Cleveland, OH 44106 USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
827
引用
收藏
页码：S382 / S383
页数：2
相关论文
共 50 条
  • [21] Effects of Age on Glycemic Control in Patients With Type 2 Diabetes Treated with Insulin Detemir: A Post-Hoc Analysis of the PREDICTIVE™ 303 Study
    Anuj Bhargava
    Vicky Chan
    Edward S. Kimball
    David S. Oyer
    Drugs & Aging, 2016, 33 : 135 - 141
  • [22] Effects of Age on Glycemic Control in Patients With Type 2 Diabetes Treated with Insulin Detemir: A Post-Hoc Analysis of the PREDICTIVE™ 303 Study
    Bhargava, Anuj
    Chan, Vicky
    Kimball, Edward S.
    Oyer, David S.
    DRUGS & AGING, 2016, 33 (02) : 135 - 141
  • [23] Efficacy and Safety of Semaglutide 0.5 mg vs. Dulaglutide 1.5 mg Once Weekly in Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 7
    Pratley, Richard E.
    Aroda, Vanita R.
    Gondolf, Theis
    Hansen, Thomas
    Lingvay, Ildiko
    Luedemann, Joerg
    Skjoeth, Trine Vang
    Viljoen, Adie
    DIABETES, 2019, 68
  • [24] Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
    Frias, Juan P.
    Bonora, Enzo
    Nevarez Ruiz, Luis
    Li, Ying G.
    Yu, Zhuoxin
    Milicevic, Zvonko
    Malik, Raleigh
    Bethel, M. Angelyn
    Cox, David A.
    DIABETES CARE, 2021, 44 (03) : 765 - 773
  • [25] A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes
    Raskin, P
    Rendell, M
    Riddle, MC
    Dole, JF
    Freed, MI
    Rosenstock, J
    DIABETES CARE, 2001, 24 (07) : 1226 - 1232
  • [26] Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
    Chen, Ying-Hua
    Li, Hui-Zhi
    Tang, Zhao-Sheng
    Xu, Lei
    Wang, Hua
    Feng, Bo
    DIABETES THERAPY, 2019, 10 (02) : 463 - 471
  • [27] Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
    Ying-Hua Chen
    Hui-Zhi Li
    Zhao-Sheng Tang
    Lei Xu
    Hua Wang
    Bo Feng
    Diabetes Therapy, 2019, 10 : 463 - 471
  • [28] Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials
    Jodar, Esteban
    Romera, Irene
    Wang, Qianqian
    Roche, Sarah Louise
    Garcia-Perez, Luis-Emilio
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 631 - 640
  • [29] Efficacy of metformin therapy in patients with type 2 diabetes mellitus poorly controlled with insulin therapy
    Cortés, MB
    Arencibia, DM
    Brier, FL
    Pino, AO
    Domínguez, AC
    Mogollón, EJN
    REVISTA CLINICA ESPANOLA, 2000, 200 (02): : 74 - 76
  • [30] Rosiglitazone (RSG) improves glycemic control in poorly controlled, insulin-treated type 2 diabetes (T2D)
    Raskin, P
    Dole, JF
    Rappaport, EB
    DIABETES, 1999, 48 : A94 - A94
12345